Bruker Corporation
BRKR
Positions held
Your positionsBRKR isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Bruker Corporation operates in the growing medical devices industry, which is expected to expand as healthcare demands increase globally.
- Revenue increased by 2% compared to the prior quarter, reaching $838 million.
- Gross margin improved to 49.6%, up from 46.1% in the previous quarter.
- Despite its growth potential, Bruker has faced challenges with profitability, as indicated by a negative net income of $52 million in the latest quarter.
- The company's operating margin was only 9.9%, which is lower than the previous quarter's 11.4%.
- The debt-to-equity ratio stands at 76.16, indicating a relatively high level of debt compared to equity.
Fundamentals
| Market cap | $8.82B | Enterprise value | $10.55B | Trailing P/E | — | Forward P/E | 24.01 |
| PEG | 1.52 | Price / book | 3.71 | Beta | 1.22 | Dividend yield | 0.35% |
| Revenue growth | 5.2% | Earnings growth | — | Gross margin | 48.5% | Operating margin | 9.9% |
| Profit margin | -2.0% | ROE | -3.0% | ROA | 3.1% | Debt / equity | 0.76 |
| Current ratio | 1.85 | Free cash flow | $179.94M | Analyst recommendation | buy | Mean target | $63.67 |
| 52w high | $66.98 | 52w low | $32.37 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $839M | $823M | $977M | $861M | $797M | — |
| Op margin | 9.9% | 4.4% | 11.4% | 4.1% | 3.3% | — |
| Net income | -$52.0M | $14.4M | $26.0M | -$59.6M | $7.6M | — |
| Gross margin | 49.6% | 46.1% | 46.0% | 44.1% | 44.9% | — |
| Gross profit | $416M | $380M | $449M | $379M | $358M | — |
| Operating income | $82.8M | $36.4M | $112M | $35.0M | $26.3M | — |
- Revenue +2% vs prior quarter ($838M vs $823M).
- Gross margin 49.6% (was 46.1% prior quarter).
- Operating margin expanded to 9.9%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.4B | $3.4B | $3.0B | $2.5B | — |
| Op margin | 6.9% | 11.3% | 16.5% | 18.3% | — |
| Net income | -$8.6M | $113M | $427M | $297M | — |
| Gross margin | 45.9% | 49.0% | 51.0% | 51.6% | — |
| Gross profit | $1.6B | $1.6B | $1.5B | $1.3B | — |
| Operating income | $236M | $379M | $489M | $462M | — |
Headlines — positive tone
• [OK · fundamentals] Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC B
News
2026-10-09 · Why Is Bruker (BRKR) Getting Attention For Its Human Plasma Proteome Atlas?
2026-10-08 · Bruker (BRKR), Why Is Its Latest Update Drawing Fresh Attention?
2026-10-08 · Bruker Gains 66.3% in a Year: What's Driving the Rally?
2026-10-07 · 3 Cash-Producing Stocks We Steer Clear Of
2026-10-05 · Are Options Traders Betting on a Big Move in Bruker Stock?
2026-10-05 · 1 Surging Stock to Target This Week and 2 We Question
2026-10-02 · QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel
2026-09-26 · Bruker Sees AI-Fueled Semiconductor Demand, Targets Critical Q4 Revenue Rebound
2026-09-21 · Is Bruker (BRKR) Using Flagship Academic NMR Deals To Deepen Its High-End Moat?
2026-09-21 · Bruker Gets More Than $6 Million Order From University of California, Berkeley
Price (daily)
Full chart · RSI · MACD · patterns